Solution NMR studies of the Aβ(1-40) and Aβ(1-42) peptides establish that the met35 oxidation state affects the mechanism of amyloid formation

被引:485
作者
Hou, LM
Shao, HY
Zhang, YB
Li, H
Menon, NK
Neuhaus, EB
Brewer, JM
Byeon, IJL
Ray, DG
Vitek, MP
Iwashita, T
Makula, RA
Przybyla, AB
Zagorski, MG [1 ]
机构
[1] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA
[2] Univ Georgia, Dept Biochem, Athens, GA 30602 USA
[3] Ohio State Univ, Dept Chem, Chem Instrumentat Ctr, Columbus, OH 43210 USA
[4] Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27710 USA
[5] Suntory Inst Bioorgan Res, Osaka 618, Japan
关键词
D O I
10.1021/ja036813f
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The pathogenesis of Alzheimer's disease is characterized by the aggregation and fibrillation of the 40-residue Abeta(1-40) and 42-residue Abeta(1-42) peptides into amyloid plaques. The structural changes associated with the conversion of monomeric Abeta peptide building blocks into multimeric fibrillar beta-strand aggregates remain unknown. Recently, we established that oxidation of the methionine-35 side chain to the sulfoxide (Met35(red) --> Met35(ox)) significantly impedes the rate of aggregation and fibrillation of the Abeta peptide. To explore this effect at greater resolution, we carefully compared the H-1, N-15, and C-13 NMR chemical shifts of four Abeta peptides that had the Met35 reduced or oxidized (Abeta(1- 40)Met35(red), Abeta(1-40)Met35(ox), Abeta(1-42)Met35(red), and Abeta(1-42)Met35(ox)). With the use of a special disaggregation protocol, the highly aggregation prone Abeta pepticles could be studied at higher, millimolar concentrations (as required by NMR) in aqueous solution at neutral pH, remaining largely monomeric at 5 degreesC as determined by sedimentation equilibrium studies. The NOE, amide-NH temperature coefficients, and chemical shift indices of the (1)Halpha, (13)Calpha, and (13)Cbeta established that the four peptides are largely random, extended chain structures, with the Met35(ox) reducing the propensity for beta-strand structure at two hydrophobic regions (Leu17-Ala21 and Ile31-Val36), and turn- or bendlike structures at Asp7-Glu11 and Phe20-Ser26. Additional NMR studies monitoring changes that occur during aging at 37 degreesC established that, along with a gradual loss of signal/noise, the Met35(ox) significantly hindered upfield chemical shift movements of the 2H NMR signals for the His6, His13, and His14 side chains. Taken together, the present NMR studies demonstrate that the Met35(red) - Met35(ox) conversion prevents aggregation by reducing both hydrophobic and electrostatic association and that the Abeta(1-40)Met35(ox), Abeta(1-40)Met35(ox), Abeta(1-42)Met35(red), and Abeta(1-42)Met35(ox) peptides may associate differently, through specific, sharp changes in structure during the initial stages of aggregation.
引用
收藏
页码:1992 / 2005
页数:14
相关论文
共 80 条
  • [1] ASSOCIATION OF BIOMOLECULAR SYSTEMS VIA PULSED-FIELD GRADIENT NMR SELF-DIFFUSION MEASUREMENTS
    ALTIERI, AS
    HINTON, DP
    BYRD, RA
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (28) : 7566 - 7567
  • [2] SOLUTION STRUCTURES OF BETA PEPTIDE AND ITS CONSTITUENT FRAGMENTS - RELATION TO AMYLOID DEPOSITION
    BARROW, CJ
    ZAGORSKI, MG
    [J]. SCIENCE, 1991, 253 (5016) : 179 - 182
  • [3] METHODOLOGICAL ADVANCES IN PROTEIN NMR
    BAX, A
    GRZESIEK, S
    [J]. ACCOUNTS OF CHEMICAL RESEARCH, 1993, 26 (04) : 131 - 138
  • [4] Two-dimensional structure of β-amyloid(10-35) fibrils
    Benzinger, TLS
    Gregory, DM
    Burkoth, TS
    Miller-Auer, H
    Lynn, DG
    Botto, RE
    Meredith, SC
    [J]. BIOCHEMISTRY, 2000, 39 (12) : 3491 - 3499
  • [5] Amyloid β-protein (Aβ) assembly:: Aβ40 and Aβ42 oligomerize through distinct pathways
    Bitan, G
    Kirkitadze, MD
    Lomakin, A
    Vollers, SS
    Benedek, GB
    Teplow, DB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (01) : 330 - 335
  • [6] BOYES BE, 1995, 14 AM PEPT S COL OH
  • [7] BURDICK D, 1992, J BIOL CHEM, V267, P546
  • [8] Designing conditions for in vitro formation of amyloid protofilaments and fibrils
    Chiti, F
    Webster, P
    Taddei, N
    Clark, A
    Stefani, M
    Ramponi, G
    Dobson, CM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) : 3590 - 3594
  • [9] Solution structure of amyloid β-peptide(1-40) in a water-micelle environment.: Is the membrane-spanning domain where we think it is?
    Coles, M
    Bicknell, W
    Watson, AA
    Fairlie, DP
    Craik, DJ
    [J]. BIOCHEMISTRY, 1998, 37 (31) : 11064 - 11077
  • [10] Emerging β-amyloid therapies for the treatment of Alzheimer's disease
    Conway, KA
    Baxter, EW
    Felsenstein, KM
    Reitz, AB
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (06) : 427 - 447